Navigation Links
GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
Date:2/16/2010

Washington, DC Combining tamoxifen, the world's most prescribed breast cancer agent, with a compound found in the flowering plant feverfew may prevent initial or future resistance to the drug, say researchers at Georgetown Lombardi Comprehensive Cancer Center.

The finding, reported online in FASEB Feb. 12, provides new insight into the biological roots of that resistance, and also tests a novel way to get around it.

"A solution to tamoxifen resistance is sorely needed, and if a strategy like this can work, it would make a difference in our clinical care of breast cancer," says the study's lead investigator, Robert Clarke, PhD, DSc, a professor of oncology and physiology & biophysics at Lombardi, a part of Georgetown University Medical Center (GUMC). Clarke is also the interim director of GUMC's Biomedical Graduate Research Organization.

Clarke added that the purified research chemical they tested, parthenolide, a derivative of feverfew, is being tested by other scientists as treatment for a variety of cancers, as well as other health conditions. Feverfew has long been a staple of natural medicine, and is particularly known for its effects on headaches and arthritis. Latin for "fever reducer," feverfew is a common garden bush with small daisy-like flowers.

"The chemical clearly has potential, and we ought to be able to figure out fairly quickly if it can help solve tamoxifen's resistance problem," Clarke says.

Tamoxifen is a treatment of choice for breast cancer that is estrogen receptor positive (ER+), meaning that the hormone estrogen drives cancer growth. Most newly diagnosed breast cancers about 70 percent - fall into that category. But about half of these cancers do not initially respond to tamoxifen, which is designed to block the hormone from binding to the cell's protein receptor, and many patients that do respond are at risk for developing resistance and cancer relapse.

In this study, Clarke and a team of resear
'/>"/>

Contact: Karen Mallet
km463@georgetown.edu
215-514-9751
Georgetown University Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Mombo from Comfort & Harmony ... US Lactation Consultant Association (USLCA) May 2nd – 5th. ... other health professionals. , The USLCA annual conference ... discover and learn about the latest trends in lactation. ... nursing pillows, which new mothers use to help support ...
(Date:5/20/2013)... 2013 Mirena IUD lawsuit ... litigation recently established in U.S. District Court, Southern District ... to court records, the litigation’s first Status Conference was ... Plaintiff’s leadership positions were discussed. So far, at ... District of New York, all of which allege that ...
(Date:5/20/2013)... Co-founder of Atlanta SEO company EverSpark Interactive, ... 5th International INVEST Domaining & Internet Marketing Conference in ... and independent individuals from around the world to discuss ... The 2013 conference will take place at the Mexico ... to 21. A networking city tour day is on ...
(Date:5/20/2013)... May 20, 2013 Nearly 20 percent of kidneys ... are refused for transplant due to factors ranging from ... units to the organ going too long without blood ... these organs could be "recycled" to help solve the ... Forest Baptist Medical Center and colleagues, reporting in the ...
(Date:5/20/2013)... 2013 Horizon NJ Health, New Jersey’s ... that it has earned a Commendable Accreditation status ... NJ Health is a wholly owned subsidiary of Horizon ... NCQA Health Plan Accreditation is a nationally recognized program ... health plans provide to their members. Health Plan Accreditation ...
Breaking Medicine News(10 mins):Health News:Comfort & Harmony™ Exhibited mombo™ Nursing Pillow at USLCA’s First Inaugural Conference 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 3Health News:EverSpark CEO to be Keynote Speaker at 5th International INVEST Domaining & Internet Marketing Conference in Mexico City 2Health News:Study suggests new source of kidneys for transplant 2Health News:Horizon NJ Health Awarded Commendable Accreditation by NCQA 2Health News:Horizon NJ Health Awarded Commendable Accreditation by NCQA 3
... ,Kick Butts Day, at 11 a.m. in Kettering, ... leaders from Ohio will hold a press conference on,Wednesday, ... how tobacco,companies take advantage of the lack of government ... aimed at hooking kids and,preventing current smokers from quitting. ...
... MIAMI, March 31 According to the World ... blacks, but,many Latinos and a few elderly Whites ... total incurable Glaucoma-Blindness,("White-Canes"). Most lack the opportunity to ... them of all their sight. Dr. Robert,Welsh, a ...
... highlights research on Blue Cross ... care utilization, EAGAN, Minn., March 31 In ... Quarterly, Blue Cross and Blue,Shield of Minnesota (Blue Cross) ... percent fewer visits to the emergency room and,had an ...
... 17,000 people with coronary artery disease or diabetes , , ... ACE inhibitor drug was as effective in reducing deaths, ... patients as a newer and more expensive angiotensin-receptor blocker ... The study of more than 17,000 people with coronary ...
... (Baltimore, MD) On April 2, the Kennedy Krieger ... Awareness Month with the one-year anniversary of the Interactive ... Launched in April 2007 by the Kennedy Krieger Institute, ... of causes, treatments, and the search for a possible ...
... Those Living with Epilepsy, TITUSVILLE, N.J., March 31 ... It has the ability to relay our deepest feelings ... strokes. For people,with epilepsy, art can be a valuable ... serious neurological condition., The sixth annual Expressions of ...
Cached Medicine News:Health News:Ohio Faith Leaders Call on Sen. Voinovich to Cosponsor Legislation to Protect Kids From Tobacco 2Health News:New Welsh 'Self-Test' to Cure Glaucoma, the Leading Cause of Preventable Blindness 2Health News:Blue Cross' Consumer-directed Health Plan - Options Blue - Members Not Sacrificing Health for the Sake of Saving Money 2Health News:Blue Cross' Consumer-directed Health Plan - Options Blue - Members Not Sacrificing Health for the Sake of Saving Money 3Health News:ACE Inhibitor as Effective as More Expensive Blood Pressure Drug 2Health News:First national autism registry shows notable impact on autism research in opening year 2Health News:People with Epilepsy Encouraged to Submit Artwork as Part of National Expressions of Courage(R) Art Contest 2Health News:People with Epilepsy Encouraged to Submit Artwork as Part of National Expressions of Courage(R) Art Contest 3Health News:People with Epilepsy Encouraged to Submit Artwork as Part of National Expressions of Courage(R) Art Contest 4
(Date:5/20/2013)... 20, 2013  Hill-Rom Holdings, Inc. (NYSE: ... presentation at the 38 th Annual Deutsche Bank ... on May 30, 2013, at 1:30 p.m. EDT. ... are invited to listen to the live discussion via ... it directly at http://www.media-server.com/m/p/f7bj3q84 . A recorded replay ...
(Date:5/20/2013)...  Echo Pharma Acquisition Limited ("Royalty Pharma") today announced, ... (the "Announcement"), a firm intention to increase its offer ... to $12.50 per share in cash.  The increased offer ... due diligence.  The $1.00 per share net cash right ... to waive down the Acceptance Threshold for the increased ...
(Date:5/20/2013)... Sequent Medical, Inc. announced today that it ... family of WEB ® Aneurysm Embolization Devices, and ... in select neurovascular centers in Europe.  The SL family ... enable physicians to treat a broader range of aneurysms ... are made possible by further advancement of Sequent Medical,s ...
Breaking Medicine Technology:Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 4Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 5Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 6Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 7Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 8Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 9Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 10Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 11Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices 2
... pleased to announce the publication of a new syndicated ... report covers the use of biologics for the treatment ... quarterly series, focuses on current and future use of ... of the key brands, barriers to broader usage, sales ...
... Nov. 2, 2010 Cypin Production, a leader in ... and China, is pleased to announce the already-high interest ... Strategies and Partnership Models for R&D Success". ... at the Hub Cira Centre in Philadelphia, is being ...
Cached Medicine Technology:Rheumatoid Arthritis Patient Share of Actemra Projected to Exceed Patient Share of Cimzia and Simponi Among the Medicare Population 2Cypin Production Announces Launch of U.S./China BioPharma Conference: 2
Ahmed Glaucoma Valve (small size) with Pars Plana Clip ....
Ahmed Glaucoma Valve....
... biocompatibility is established. Provides a robust and ... correct positioning on the globe. Pressure Ridge ... when covered by Tenons tissue, acts as ... hypotony. The range of implants allows the ...
... Goldmann standard automatic or manual kinetic ... white/white, blue/yellow or red/white stimuli/background colors. ... classic 4-2 threshold strategy. Examination with ... (including 30-2, 24-2, and 10-2). Gray-scale/ ...
Medicine Products: